Larvol Delta - Abion-unveils-phase-2-cutoff-results-for-vabametkib-and-combination-strategy-with-lazertinib-at-ASCO-2024

vabametkib (ABN401) - Abion

https://www.koreabiomed.com/news/articleView.html?idxno=24257

Jun 11, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next